Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration
Clinical trial NCT03038880 · COMPLETED
Trial details
- NCT number
- NCT03038880
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-27
- Primary completion
- 2018-01-11
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.